Exelixis | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Amgen USD 8.15B 936M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Bayer EUR 13.74B 2.01B 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Cytokinetics USD 1.6M 15.33M 2025-03
Eisai JPY 188.24B 27.9B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Exelixis USD 555.4M 11.35M 2025-03
Genmab DKK 5.28B 59.13B 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Incyte USD 1.05B 128.7M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
MacroGenics USD 19.35M 91.35M 2024-12
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Novartis USD 13.15B 330M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Sanofi EUR 11.26B 3.5B 2024-12
Takeda JPY 1.05T 90B 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
Xencor USD 32.73M 37.29M 2025-03



Exelixis Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.